Brief Reportbenzodiazepine (cas 12794-10-4)s vs barbiturates for alcohol withdrawal: Analysis of 3 different treatment protocols
-
Add time:09/02/2019 Source:sciencedirect.com
IntroductionAlcohol withdrawal treatment varies widely. Benzodiazepines are the standard of care, with rapid onset and long durations of action. Recent drug shortages involving IV benzodiazepines have required incorporation of alternative agents into treatment protocols. Phenobarbital has similar pharmacokinetics to select benzodiazepines frequently used for alcohol withdrawal. The objective of this study is to describe the effectiveness and safety of our institutional protocols during three time periods utilizing benzodiazepines and barbiturates for the acute treatment of alcohol withdrawal in the emergency department.
We also recommend Trading Suppliers and Manufacturers of benzodiazepine (cas 12794-10-4). Pls Click Website Link as below: cas 12794-10-4 suppliers
Prev:Influence of Abuse History on Concurrent benzodiazepine (cas 12794-10-4) and Opioid Use in Chronic Pain Patients
Next:Original StudyAssociation of benzodiazepine (cas 12794-10-4) and Anticholinergic Drug Usage With Incident Dementia: A Prospective Cohort Study of Community-Dwelling Older Adults) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Inappropriate prescription of benzodiazepine (cas 12794-10-4)s in acutely hospitalized older patients09/04/2019
- Original StudyAssociation of benzodiazepine (cas 12794-10-4) and Anticholinergic Drug Usage With Incident Dementia: A Prospective Cohort Study of Community-Dwelling Older Adults09/03/2019
- Influence of Abuse History on Concurrent benzodiazepine (cas 12794-10-4) and Opioid Use in Chronic Pain Patients09/01/2019
- ReviewThe benzodiazepine (cas 12794-10-4) Binding Sites of GABAA Receptors08/31/2019
- Review ArticleThe Association Between benzodiazepine (cas 12794-10-4)s and Survival in Patients With Cancer: A Systematic Review08/30/2019
- 7New benzodiazepine (cas 12794-10-4)s for sedation08/29/2019
- ReviewAn expanding world of new psychoactive substances—designer benzodiazepine (cas 12794-10-4)s08/28/2019
- ReviewThe epidemiology of benzodiazepine (cas 12794-10-4) misuse: A systematic review08/27/2019


